CA2288027A1 - Analogues de bradykinine inhibiteurs selectifs de l'activation cellulaire - Google Patents

Analogues de bradykinine inhibiteurs selectifs de l'activation cellulaire Download PDF

Info

Publication number
CA2288027A1
CA2288027A1 CA002288027A CA2288027A CA2288027A1 CA 2288027 A1 CA2288027 A1 CA 2288027A1 CA 002288027 A CA002288027 A CA 002288027A CA 2288027 A CA2288027 A CA 2288027A CA 2288027 A1 CA2288027 A1 CA 2288027A1
Authority
CA
Canada
Prior art keywords
pro
arg
amino acids
thrombin
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002288027A
Other languages
English (en)
Inventor
Alvin H. Schmaier
Ahmed A.K. Hasan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Michigan
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2288027A1 publication Critical patent/CA2288027A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0815Tripeptides with the first amino acid being basic
    • C07K5/0817Tripeptides with the first amino acid being basic the first amino acid being Arg
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043Kallidins; Bradykinins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/18Kallidins; Bradykinins; Related peptides

Abstract

La présente invention concerne des analogues de la bradykinine, des compositions à base de tels peptides, et des procédés permettant d'inhiber l'activation plaquettaire ou cellulaire induite par la thrombine. Ces analogues de bradykinine sont mono ou multisegments. L'invention concerne également un procédé permettant d'identifier des composés inhibant sélectivement l'activation plaquettaire ou cellulaire induite par la thrombine.
CA002288027A 1997-04-23 1998-04-21 Analogues de bradykinine inhibiteurs selectifs de l'activation cellulaire Abandoned CA2288027A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4608597P 1997-04-23 1997-04-23
US60/046,085 1997-04-23
PCT/US1998/008015 WO1998047522A1 (fr) 1997-04-23 1998-04-21 Analogues de bradykinine inhibiteurs selectifs de l'activation cellulaire

Publications (1)

Publication Number Publication Date
CA2288027A1 true CA2288027A1 (fr) 1998-10-29

Family

ID=21941533

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002288027A Abandoned CA2288027A1 (fr) 1997-04-23 1998-04-21 Analogues de bradykinine inhibiteurs selectifs de l'activation cellulaire

Country Status (5)

Country Link
EP (1) EP1019070A4 (fr)
JP (1) JP2001518119A (fr)
CA (1) CA2288027A1 (fr)
IL (1) IL132546A0 (fr)
WO (1) WO1998047522A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544750B1 (en) * 1999-08-17 2003-04-08 Thromgen, Inc. Peptide analogs as selective inhibitors of thrombin activation of protease activated receptor 1
US7879792B2 (en) * 2005-06-02 2011-02-01 The Regents Of The University Of Michigan Synthetic peptide inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
JP5937612B2 (ja) 2010-12-02 2016-06-22 ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company 血液安定剤を含む採血用デバイス

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585757A (en) * 1984-07-27 1986-04-29 Texas Tech University Health Sciences Center Hypotensive active peptides
ATE114160T1 (de) * 1989-01-24 1994-12-15 Aphton Corp Immunogenische zusammensetzungen gegen gastrin- peptide.
SE468516B (sv) * 1991-06-14 1993-02-01 Kabigen Ab Nya polypeptider vilka kan utvinnas fraan tunntarmen och deras anvaendning
US5472945A (en) * 1991-08-13 1995-12-05 Temple University- Of The Commonwealth System Of Higher Education Modulation of blood pressure and inhibition of platelet activation with kininogen fragment
EP0871464B1 (fr) * 1995-06-09 2003-04-02 The Regents Of The University Of Michigan Analogues de la bradykinine utilises comme inhibiteurs selectifs de la thrombine

Also Published As

Publication number Publication date
AU7252898A (en) 1998-11-13
WO1998047522A1 (fr) 1998-10-29
EP1019070A4 (fr) 2001-05-16
EP1019070A1 (fr) 2000-07-19
JP2001518119A (ja) 2001-10-09
IL132546A0 (en) 2001-03-19
AU734935B2 (en) 2001-06-28

Similar Documents

Publication Publication Date Title
EP0578728B1 (fr) INHIBITEURS DE L'AGREGATION PLAQUETTAIRE PRESENTANT UNE SPECIFICITE ELEVEE POUR GP IIbIIIa
US6982249B1 (en) Bradykinin analogs as selective inhibitors of cell activation
EP0871464B1 (fr) Analogues de la bradykinine utilises comme inhibiteurs selectifs de la thrombine
Stewart Bradykinin antagonists: discovery and development
Krstenansky et al. Development of MDL 28,050, a small stable antithrombin agent based on a functional domain of the leech protein, hirudin
US5498601A (en) Platelet aggregation-inhibiting peptides
CA2045692A1 (fr) Procedes de production des inhibiteurs polypeptiques de l'activation plaquettaire et methodes, combinaisons et compositions faisant appel a ces procedes
US7879792B2 (en) Synthetic peptide inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
WO1993003748A1 (fr) Modulation de la tension arterielle et inhibition de l'activation plaquettaire a l'aide d'un fragment de kininogene
AU764707B2 (en) Peptide analogs as selective inhibitors of thrombin activation of protease activated receptor 1
CA2288027A1 (fr) Analogues de bradykinine inhibiteurs selectifs de l'activation cellulaire
AU734935C (en) Bradykinin analogs as selective inhibitors of cell activation
Stewart et al. Metabolism-resistant bradykinin antagonists: development and applications
AU761624B2 (en) Bradykinin analogs as selective inhibitors of cell activation
US20040220110A1 (en) Synthetic peptide analogs of Arg-Pro-Pro-Gly-Phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
EP0702696B1 (fr) Peptides trifonctionnels antithrombiniques et antiplaquettaires
CA1180006A (fr) Pseudopeptides a action therapeutique, composes les contenant et methode de preparation et d'utilisation
WO1999065944A1 (fr) INHIBITEURS PEPTIDIQUES DE αVβ3 ET αVβ¿5?

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued
FZDE Discontinued

Effective date: 20110421